Rishi Rajan Vohora, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 157 Union St, Marlborough, MA 01752 Phone: 508-624-9687 |
Joseph L Bouchard, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 159 Union St, Marlborough, MA 01752 Phone: 508-624-9687 Fax: 508-624-9689 |
Dr. Robert Charles Sumner, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 28 Lord Rd, Suite 255, Marlborough, MA 01752 Phone: 508-485-7660 Fax: 508-481-4540 |
Daniel Carlucci, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 159 Union St, Suite 103, Marlborough, MA 01752 Phone: 508-624-9687 Fax: 508-739-1538 |
News Archive
International food import bills could exceed $1 trillion in 2010, the U.N. Food and Agriculture Organization (FAO) said Wednesday in its Food Outlook report, which found that wheat and other food staple prices have increased alarmingly over the past year, the Associated Press reports.
Almirall strengthens its position in the respiratory field with a positive development progress of another New Chemical Entity (NCE). LAS190792 is a new dual long-acting Muscarinic Antagonist β2 Agonist (MABA), which combines two bronchodilator mechanisms in a single molecule for the treatment of COPD.
Today, the Association for Molecular Pathology (AMP) presented public comments to the Secretary's Advisory Committee on Genetics, Health and Society (SACHGS) meeting focused on whole genome sequencing. In anticipation of advances in sequencing and its incorporation into clinical practice, AMP raised ethical and laboratory practice concerns for the Committee's consideration.
Female cognitive ability can limit how melodious or handsome males become over evolutionary time, biologists from The University of Texas at Austin, Louisiana State University Health Sciences Center and the Smithsonian Tropical Research Institute have observed.
The drug pazopanib (Votrient) slowed the progression of advanced renal cell carcinoma (RCC), a form of kidney cancer, in patients by 54% percent, according to a new study published in the Journal of Clinical Oncology.
› Verified 5 days ago